scholarly article | Q13442814 |
P356 | DOI | 10.1016/S0009-9120(03)00096-1 |
P698 | PubMed publication ID | 14563446 |
P50 | author | Wojciech Kisielewski | Q59704720 |
P2093 | author name string | Maurice M A L Pelsers | |
Jan F C Glatz | |||
Andrzej Namiot | |||
Wim T Hermens | |||
Zbigniew Namiot | |||
Marcin Januszkiewicz | |||
P2860 | cites work | Discrimination Between Myocardial and Skeletal Muscle Injury by Assessment of the Plasma Ratio of Myoglobin Over Fatty Acid–Binding Protein | Q34297538 |
Intestinal fatty acid binding protein is available for diagnosis of intestinal ischaemia: immunochemical analysis of two patients with ischaemic intestinal diseases | Q34408362 | ||
Fatty acid-binding protein in small intestine. Identification, isolation, and evidence for its role in cellular fatty acid transport | Q34464839 | ||
The recovery of function and microcirculation in small intestinal loops following ischaemia | Q34475523 | ||
Progress in myocardial damage detection: new biochemical markers for clinicians | Q41367903 | ||
Cellular fatty acid-binding proteins: their function and physiological significance | Q41397842 | ||
Plasma intestinal fatty acid binding protein in neonates with necrotizing enterocolitis: a pilot study | Q44865503 | ||
Elevated intestinal fatty acid binding protein and gastrointestinal complications following cardiopulmonary bypass: a preliminary analysis | Q44883997 | ||
Measurement of myocardial infarct size from plasma fatty acid-binding protein or myoglobin, using individually estimated clearance rates | Q47246076 | ||
Recombinant human heart-type fatty acid-binding protein as standard in immunochemical assays | Q47795781 | ||
Association between gastric intramucosal pH and splanchnic endotoxin, antibody to endotoxin, and tumor necrosis factor-alpha concentrations in patients undergoing cardiopulmonary bypass. | Q51672701 | ||
Plasma concentration of intestinal- and liver-FABP in neonates suffering from necrotizing enterocolitis and in healthy preterm neonates. | Q52026486 | ||
Elevation of circulating intestinal fatty acid binding protein in a luminal contents-initiated model of NEC | Q70649317 | ||
Intestinal fatty acid-binding protein is a useful diagnostic marker for mesenteric infarction in humans | Q70912541 | ||
Small bowel allograft rejection detected by serum intestinal fatty acid-binding protein is reversible | Q71085134 | ||
Human intestinal fatty acid binding protein: report of an assay with studies in normal volunteers and intestinal ischemia | Q73151870 | ||
One-step enzyme-linked immunosorbent assay (ELISA) for plasma fatty acid-binding protein | Q73354803 | ||
Lack of utility of intestinal fatty acid binding protein levels in predicting intestinal allograft rejection | Q73930452 | ||
Development of a simple whole blood panel test for detection of human heart-type fatty acid-binding protein | Q74146978 | ||
Human intestinal fatty acid binding protein in peritoneal fluid is a marker of intestinal ischemia | Q74339590 | ||
Multicenter evaluation of an amperometric immunosensor for plasma fatty acid-binding protein: an early marker for acute myocardial infarction | Q77925906 | ||
P433 | issue | 7 | |
P304 | page(s) | 529-535 | |
P577 | publication date | 2003-10-01 | |
P1433 | published in | Clinical Biochemistry | Q5133749 |
P1476 | title | Intestinal-type and liver-type fatty acid-binding protein in the intestine. Tissue distribution and clinical utility | |
P478 | volume | 36 |
Q47163293 | A New Proposal for the Pathogenic Mechanism of Non-Coeliac/Non-Allergic Gluten/Wheat Sensitivity: Piecing Together the Puzzle of Recent Scientific Evidence |
Q37294167 | Accuracy of the serum intestinal fatty-acid-binding protein for diagnosis of acute intestinal ischemia: a meta-analysis |
Q35640599 | Altered CD4+ T cell homing to the gut impairs mucosal immune reconstitution in treated HIV-infected individuals |
Q91878345 | Association between endotoxemia and enterocyte injury and clinical course in patients with gram-positive septic shock: A posthoc analysis of a prospective observational study |
Q54174857 | Association of L-FABP T94A and MTP I128T polymorphisms with hyperlipidemia in Chinese subjects. |
Q35800550 | Association of a Human FABP1 Gene Promoter Region Polymorphism with Altered Serum Triglyceride Levels |
Q37317771 | Bacteroides are associated with GALT iNKT cell function and reduction of microbial translocation in HIV-1 infection |
Q39325747 | Biomarkers and non-invasive tests for gastrointestinal mucositis |
Q36859128 | Biomarkers for radiation-induced small bowel epithelial damage: an emerging role for plasma Citrulline. |
Q30275811 | Biomarkers of Environmental Enteropathy, Inflammation, Stunting, and Impaired Growth in Children in Northeast Brazil |
Q41902202 | Bowel Ischemia in ICU Patients: Diagnostic Value of I-FABP Depends on the Interval to the Triggering Event |
Q93034302 | Brief Report: Gut Structural Damage: an Ongoing Process in Chronically Untreated HIV Infection |
Q90693849 | Brief Report: Zinc Supplementation and Inflammation in Treated HIV |
Q50992669 | Circulating intestinal fatty acid-binding protein (I-FABP) levels in acute decompensated heart failure. |
Q35054010 | Circulating levels of fatty acid-binding protein family and metabolic phenotype in the general population |
Q33281085 | Comparative proteomic analysis of cell lines and scrapings of the human intestinal epithelium |
Q37378495 | Cytokine-like Activity of Liver Type Fatty Acid Binding Protein (L-FABP) Inducing Inflammatory Cytokine Interleukin-6. |
Q63515300 | Decreased expression of Intestinal I- and L-FABP levels in rare human genetic lipid malabsorption syndromes |
Q30268540 | Determinant Variables, Enteric Pathogen Burden, Gut Function, and Immune-Related Inflammatory Biomarkers Associated with Childhood Malnutrition: A Prospective Case-Control Study in Northeastern Brazil |
Q52053440 | Development of a porcine small intestinal cDNA micro-array: characterization and functional analysis of the response to enterotoxigenic E. coli. |
Q37358567 | Diagnosis and management of splanchnic ischemia |
Q51058766 | Diagnosis of ischemic small bowel disease by measurement of serum intestinal fatty acid-binding protein in patients with acute abdomen: a multicenter, observer-blinded validation study. |
Q89928163 | Diagnostic accuracy of urinary intestinal fatty acid binding protein in detecting colorectal anastomotic leakage |
Q92002919 | Effect of Huangqin Tang on Colonic Gene Expression in Rats with Ulcerative Colitis |
Q94551906 | Effect of Huangqin Tang on Urine Metabolic Profile in Rats with Ulcerative Colitis Based on UPLC-Q-Exactive Orbitrap MS |
Q35926782 | Effects of silver nanoparticles and ions on a co-culture model for the gastrointestinal epithelium |
Q37656786 | Elevated FABP1 serum levels are associated with poorer survival in acetaminophen-induced acute liver failure |
Q40736165 | Elevated levels of circulating CDH5 and FABP1 in association with human drug-induced liver injury |
Q35071134 | Enterocyte fatty acid-binding proteins (FABPs): different functions of liver and intestinal FABPs in the intestine |
Q35814231 | Evidence for a Cystic Fibrosis Enteropathy |
Q42594413 | Expression Pattern of Fatty Acid Binding Proteins in Celiac Disease Enteropathy |
Q92124140 | Expression Signatures of Cisplatin- and Trametinib-Treated Early-Stage Medaka Melanomas |
Q44582581 | Expression pattern of L-FABP gene in different tissues and its regulation of fat metabolism-related genes in duck |
Q27322647 | Extensive expression differences along porcine small intestine evidenced by transcriptome sequencing |
Q35042217 | Fatty Acid-Binding Protein 4 (FABP4): Pathophysiological Insights and Potent Clinical Biomarker of Metabolic and Cardiovascular Diseases |
Q33223853 | Gene expression profiling of jejunal Peyer's patches in juvenile and adult pigs |
Q37440936 | Genome-wide analysis of the rat colon reveals proximal-distal differences in histone modifications and proto-oncogene expression |
Q26773267 | Gut epithelial barrier dysfunction in human immunodeficiency virus-hepatitis C virus coinfected patients: Influence on innate and acquired immunity |
Q91916978 | Gut permeability, inflammation, and bone density across the menopause transition |
Q35269130 | Host response to translocated microbial products predicts outcomes of patients with HBV or HCV infection |
Q59805967 | I-FABP Is Higher in People With Chronic HIV Than Elite Controllers, Related to Sugar and Fatty Acid Intake and Inversely Related to Body Fat in People With HIV |
Q47828822 | I-FABP is a Novel Marker for the Detection of Intestinal Injury in Severely Injured Trauma Patients. |
Q34303381 | Identification of novel biomarker candidates for the immunohistochemical diagnosis of cholangiocellular carcinoma. |
Q36199763 | Immune Activation at Sites of HIV/TB Co-Infection Contributes to the Pathogenesis of HIV-1 Disease |
Q47251751 | Immunogenicity of rotavirus vaccine (RotarixTM) in infants with environmental enteric dysfunction |
Q89775610 | Increased monocyte and T-cell activation in treated HIV+ ugandan children: associations with gut alteration and HIV factors |
Q38267212 | Insights from human congenital disorders of intestinal lipid metabolism |
Q35126230 | Interaction of enterocyte FABPs with phospholipid membranes: clues for specific physiological roles |
Q37715738 | Intestinal T lymphocyte homing is associated with gastric emptying and epithelial barrier function in critically ill: a prospective observational study. |
Q42262442 | Intestinal barrier integrity and function in infants with cholestasis |
Q37471655 | Intestinal cell damage and systemic immune activation in individuals reporting sensitivity to wheat in the absence of coeliac disease |
Q34476223 | Intestinal fatty-acid binding protein and metronidazole response in premature infants |
Q47243096 | Iron absorption from oral iron supplements given on consecutive versus alternate days and as single morning doses versus twice-daily split dosing in iron-depleted women: two open-label, randomised controlled trials |
Q91936388 | Is I-FABP not only a marker for the detection abdominal injury but also of hemorrhagic shock in severely injured trauma patients? |
Q90720520 | Ischemia/Reperfusion Injury Revisited: An Overview of the Latest Pharmacological Strategies |
Q34575989 | Kinetics of microbial translocation markers in patients on efavirenz or lopinavir/r based antiretroviral therapy |
Q51471819 | L-FABP T94A is associated with fasting triglycerides and LDL-cholesterol in women. |
Q57800469 | Leaky Gut Biomarkers in Depression and Suicidal Behavior |
Q35185218 | Loss of intestinal GATA4 prevents diet-induced obesity and promotes insulin sensitivity in mice. |
Q57111128 | Lower pretreatment gut integrity is independently associated with fat gain on antiretroviral therapy |
Q39278519 | Malnutrition in HIV-Infected Children Is an Indicator of Severe Disease with an Impaired Response to Antiretroviral Therapy |
Q36215001 | Microbial Translocation and Inflammation Occur in Hyperacute Immunodeficiency Virus Infection and Compromise Host Control of Virus Replication |
Q36558287 | Microbial translocation in the pathogenesis of HIV infection and AIDS. |
Q40478716 | Monocyte Activation Is Associated With Worse Cognitive Performance in HIV-Infected Women With Virologic Suppression. |
Q37821275 | Non-invasive assessment of barrier integrity and function of the human gut. |
Q34510967 | Novel potential interacting partners of fibronectin in spontaneous animal model of interstitial cystitis |
Q34764002 | Plasma levels of soluble CD14 independently predict mortality in HIV infection |
Q36929093 | Prediction of Gut Wall Integrity Loss in Viral Gastroenteritis by Non-Invasive Marker |
Q33812820 | Progressive proximal-to-distal reduction in expression of the tight junction complex in colonic epithelium of virally-suppressed HIV+ individuals. |
Q36282619 | Protected graft copolymer-formulated fibroblast growth factors mitigate the lethality of partial body irradiation injury |
Q37279857 | Rapid development of intestinal cell damage following severe trauma: a prospective observational cohort study. |
Q28268205 | Recent insights into the biological functions of liver fatty acid binding protein 1 |
Q92269205 | Role for diet in normal gut barrier function: developing guidance within the framework of food-labeling regulations |
Q34345547 | Role of heat-stable enterotoxins in the induction of early immune responses in piglets after infection with enterotoxigenic Escherichia coli. |
Q64245096 | Serum Bovine Immunoglobulins Improve Inflammation and Gut Barrier Function in Persons with HIV and Enteropathy on Suppressive ART |
Q64240440 | Serum Markers Associated with Severity and Outcome of Hantavirus Pulmonary Syndrome |
Q34534552 | Serum markers and intestinal mucosal injury in chronic gastrointestinal ischemia |
Q90187123 | Strongyloides stercoralis Infection in Solid Organ Transplant Patients is Associated with Eosinophil Activation and Intestinal Inflammation: A Cross-sectional Study |
Q91594611 | Superior intestinal integrity and limited microbial translocation are associated with lower immune activation in SIVmac239-infected northern pig-tailed macaques (Macaca leonina) |
Q33934080 | Switch to raltegravir decreases soluble CD14 in virologically suppressed overweight women: the Women, Integrase and Fat Accumulation Trial |
Q42128377 | Temporal profile of intestinal tissue expression of intestinal fatty acid-binding protein in a rat model of necrotizing enterocolitis. |
Q35965167 | The Interplay Between Host Genetic Variation, Viral Replication, and Microbial Translocation in Untreated HIV-Infected Individuals |
Q26992027 | The Mediterranean diet: effects on proteins that mediate fatty acid metabolism in the colon |
Q90141454 | The Role of Gastrointestinal-Related Fatty Acid-Binding Proteins as Biomarkers in Gastrointestinal Diseases |
Q34789326 | The Th17/Treg ratio, IL-1RA and sCD14 levels in primary HIV infection predict the T-cell activation set point in the absence of systemic microbial translocation |
Q28833221 | The biogenesis of chylomicrons |
Q49651262 | The effects of dietary sulfur amino acids on growth performance, intestinal morphology, enzyme activity, and nutrient transporters in weaning piglets |
Q28277155 | The intestinal barrier as an emerging target in the toxicological assessment of mycotoxins |
Q40835189 | The role of I-FABP as a biomarker of intestinal barrier dysfunction driven by gut microbiota changes in obesity. |
Q34146203 | Total intermittent Pringle maneuver during liver resection can induce intestinal epithelial cell damage and endotoxemia |
Q90451647 | Urinary I-FABP, L-FABP, TFF-3, and SAA Can Diagnose and Predict the Disease Course in Necrotizing Enterocolitis at the Early Stage of Disease |
Q36773550 | Urinary Intestinal Fatty Acid-Binding Protein Can Distinguish Necrotizing Enterocolitis from Sepsis in Early Stage of the Disease |
Q33754526 | Usefulness of intestinal fatty acid-binding protein in predicting strangulated small bowel obstruction |
Q43929358 | Value of the serum I-FABP level for diagnosing acute mesenteric ischemia |
Search more.